Acquired hepatocerebral degeneration

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 193-197

  Meissner, Wassilios ^a   Tison, François ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; DISEASE COURSE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; WILSON DISEASE;

DISEASE PROGRESSION; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 79954470585     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00011-2     Document Type: Book

References (49)

1. Baltzan M.A., Olszewski J., Zervas N. Chronic porto-hepatic encephalopathy. J Neuropathol Exp Neurol 1957, 16:410-421.
2. Bechar M., Freud M., Kott E., et al. Hepatic cirrhosis with post-shunt myelopathy. J Neurol Sci 1970, 11:101-107.
3. Berthelot P., Walker J.G., Sherlock S., et al. Arterial changes in the lungs in cirrhosis of the liver - lung spider nevi. N Engl J Med 1966, 274:291-298.
4. Bleasel A.F., Waugh R.C., McCaughan G.W. Development of chronic hepatocerebral degeneration eight years after a distal splenorenal (Warren) shunt. Gut 1989, 30:1419-1423.
5. Brunberg J.A., Kanal E., Hirsch W., et al. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR Am J Neuroradiol 1991, 12:909-914.
6. Burkhard P.R., Delavelle J., Du P.R., et al. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003, 60:521-528.
7. Butterworth R.F. Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease. Metab Brain Dis 1995, 10:1-8.
8. Butterworth R.F. Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 2007, 22:309-320.
9. Ferrara J., Gupta D., Foster E., et al. Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degeneration. Mov Disord 2008, 23:875-878.
10. Finlayson M.H., Superville B. Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 1981, 104:79-95.
11. Fischer J.E., Baldessarini R.J. False neurotransmitters and hepatic failure. Lancet 1971, 2:75-80.
12. Graham D.I., Adams J.H., Caird F.I., et al. Acquired hepatocerebral degeneration: report of an atypical case. J Neurol Neurosurg Psychiatry 1970, 33:656-662.
13. Gregorios J.B., Mozes L.W., Norenberg L.O., et al. Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies. J Neuropathol Exp Neurol 1985, 44:397-403.
14. Hauser R.A., Zesiewicz T.A., Rosemurgy A.S., et al. Manganese intoxication and chronic liver failure. Ann Neurol 1994, 36:871-875.
15. Inoue E., Hori S., Narumi Y., et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991, 179:551-555.
16. Jog M.S., Lang A.E. Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995, 10:714-722.
17. Katsuragi T., Iseki E., Kosaka K., et al. Cerebrospinal fluid manganese concentrations in patients with symmetric pallidal hyperintensities on T1 weighted MRI. J Neurol Neurosurg Psychiatry 1999, 66:551-552.
18. Klos K.J., Ahlskog J.E., Josephs K.A., et al. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol 2005, 62:1385-1390.
19. Klos K.J., Ahlskog J.E., Kumar N., et al. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology 2006, 67:1984-1989.
20. Kril J.J., Butterworth R.F. Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology 1997, 26:837-841.
21. Kulisevsky J., Pujol J., Junque C., et al. MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration?. Neurology 1993, 43:2570-2573.
22. Lee J., Lacomis D., Comu S., et al. Acquired hepatocerebral degeneration: MR and pathologic findings. AJNR Am J Neuroradiol 1998, 19:485-487.
23. Lewis M.B., MacQuillan G., Bamford J.M., et al. Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome. Neurology 2000, 54:1011.
24. Liversedge L.A., Rawson M.D. Myelopathy in hepatic disease and portosystemic venous anastomosis. Lancet 1966, 1:277-279.
25. Mousseau D.D., Perney P., Layrargues G.P., et al. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 1993, 162:192-196.
26. Pant S.S., Rebeiz J.J., Richardson E.P. Spastic paraparesis following portacaval shunts. Neurology 1968, 18:135-141.
27. Papapetropoulos S., Singer C. Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD). Mov Disord 2005, 20:1088-1089.
28. Papapetropoulos S., Tzakis A., Sengun C., et al. Case of pediatric acquired chronic hepatocerebral degeneration. Pediatr Neurol 2008, 38:67-70.
29. Park H.K., Kim S.M., Choi C.G., et al. Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration. Mov Disord 2008, 23:768-770.
30. Park S.A., Heo K. Prominent cerebellar symptoms with unusual magnetic resonance imaging findings in acquired hepatocerebral degeneration. Arch Neurol 2004, 61:1458-1460.
31. Pinarbasi B., Kaymakoglu S., Matur Z., et al. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?. J Clin Gastroenterol 2009, 43:176-181.
32. Pomier-Layrargues G., Spahr L., Butterworth R.F. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 1995, 345:735.
33. Powell E.E., Pender M.P., Chalk J.B., et al. Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 1990, 98:1079-1082.
34. Pujol A., Graus F., Peri J., et al. Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver disease. Neurology 1991, 41:1526-1527.
35. Pujol A., Pujol J., Graus F., et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993, 43:65-69.
36. Pujol J., Kulisevsky J., Moreno A., et al. Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 1996, 47:1526-1530.
37. Rao V.L., Butterworth R.F. Alterations of [3H]8-OH-DPAT and [3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci Lett 1994, 182:69-72.
38. Servin-Abad L., Tzakis A., Schiff E.R., et al. Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation. Liver Transpl 2006, 12:1161-1165.
39. Shulman L.M., Minagar A., Weiner W.J. Reversal of parkinsonism following liver transplant. Neurology 2003, 60:519.
40. Stracciari A., Guarino M., Pazzaglia P., et al. Acquired hepatocerebral degeneration: full recovery after liver transplantation. J Neurol Neurosurg Psychiatry 2001, 70:136-137.
41. Stracciari A., Mattarozzi K., D'Alessandro R., et al. Cognitive functioning in chronic acquired hepatocerebral degeneration. Metab Brain Dis 2008, 23:155-160.
42. Taylor-Robinson S.D., Oatridge A., Hajnal J.V., et al. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995, 10:175-188.
43. Thobois S., Giraud P., Debat P., et al. Orofacial dyskinesias in a patient with primary biliary cirrhosis: a clinicopathological case report and review. Mov Disord 2002, 17:415-419.
44. Ueki Y., Isozaki E., Miyazaki Y., et al. Clinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapy. Acta Neurol Scand 2002, 106:113-116.
45. van Woerkom W. La cirrhose hépatique avec altération dans les centres nerveux évoluant chez des sujets d'âge moyen. Nouvelle icônographie de la Salpétière. Clin Mal Syst Nerv 1914, 7:45-51.
46. Victor M., Adams R.D., Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 1965, 44:345-396.
47. Weissenborn K., Ehrenheim C., Hori A., et al. Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 1995, 10:219-231.
48. Weissenborn K., Berding G., Kostler H. Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metab Brain Dis 2000, 15:173-178.
49. Wijdicks E.F., Wiesner R.H. Acquired (non-Wilsonian) hepatocerebral degeneration: complex management decisions. Liver Transpl 2003, 9:993-994.